Document Detail


Cardiac resynchronization therapy: an updateimpaired left ventricular systolic function.
MedLine Citation:
PMID:  21285934     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Cardiac resynchronization therapy has been shown to reduce hospitalization and mortality, and to improve heart failure symptoms, in patients with systolic dysfunction and ventricular dyssynchrony. We review the current guidelines for cardiac resynchronization therapy, the underlying evidence, the latest developments in the field and directions of future research.
Authors:
N V Garikipati; M J Schaefer; J S Steinberg
Related Documents :
4019914 - Silent myocardial ischemia: hemodynamic changes during dynamic exercise in patients wit...
2788454 - Factor vii and extrinsic pathway inhibitor in acute coronary disease.
3665004 - Long-term prognosis of patients with variant angina.
7942544 - Extent of cardiac autonomic denervation in relation to angina on exercise test in patie...
14635384 - First successful bridge to recovery with the impella recover 100 left ventricular assis...
18926714 - Repeat intervention after invasive treatment of coronary arteries.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Minerva cardioangiologica     Volume:  59     ISSN:  0026-4725     ISO Abbreviation:  Minerva Cardioangiol     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-02-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0400725     Medline TA:  Minerva Cardioangiol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  89-100     Citation Subset:  IM    
Affiliation:
Division of Cardiology, Al-Sabah Arrhythmia Institute, St. Luke's and Roosevelt Hospitals, Columbia University College of Physicians & Surgeons, New York, NY, USA - jss7@columbia.edu.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiogenic shock: role of revascularization.
Next Document:  Iloprost in the management of peripheral arterial disease in patients with diabetes mellitus.